Business

WellPoint offloads pharmacy division

Prescription drug benefit manager Express Scripts will buy WellPoint's pharmacy benefit management division in a $4.7 billion deal.

By Emily Berry — Posted April 27, 2009

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

WellPoint Inc., the country's largest private health plan by membership, has decided to sell control of its pharmacy benefit management subsidiary NextRx, netting the health plan cash and possibly leading to more consolidation of the pharmacy benefit industry.

St. Louis-based Express Scripts, one of the largest in a now smaller field of PBMs, has agreed to purchase NextRx and will continue to provide WellPoint's members with pharmacy benefits for the next 10 years.

The companies' announcement April 13 described the deal as worth $4.7 billion, including tax benefits that will accrue to Express Scripts. Analysts estimated the sale would give WellPoint a one-time cash benefit of $2.5 billion this year, significantly boosting its cash holdings and per-share earnings.

The deal is subject to approval from the Federal Trade Commission and state regulators.

WellPoint spokeswoman Cheryl Leamon said the sale would have little direct effect on doctors who care for WellPoint's 35 million members.

"WellPoint will maintain control of the formulary, which will result in little to no impact on physician offices as a result of this transaction," she said.

Financial analysts have speculated that other large health plans, including UnitedHealth Group and Aetna, could re-examine the value of owning and operating their own PBMs. No health plans have announced their intention to sell those divisions.

Mike Winkelman, RPh, a former PBM manager and now a pharmacy benefit consultant based in West Bloomfield, Mich., said he sees a simple motivation for WellPoint's decision, one that may or may not drive the company's peers to follow suit. "My instinct is WellPoint just wanted to get some cash. It's almost like it's just moving bags of money around."

WellPoint and Express Scripts have cast the sale as a way to help patients through efficiency and deeper negotiated discounts on drugs. But Winkelman said it's likely Express Scripts will keep most, if not all, of that savings.

"How does the consumer benefit?" he said. "You have a card in your wallet that says you pay a $20 co-pay for brand names and $15 for generics -- that won't change."

Stock analysts following WellPoint reacted favorably to the deal, and WellPoint's stock price rose above $42 the day the sale was announced, a value it hadn't reached since mid-February.

"Overall this appears to be an excellent transaction for WellPoint," Deutsche Bank analyst Scott Fidel wrote in a research note the day the deal was announced.

The company's share price has dipped as low as $30 twice in the past six months. Like its competitors, WellPoint is facing diminished commercial membership due to job cuts by its employer customer base. That has already driven down operating profits, as has been the case for other large insurers.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn